Haemonetics (HAE) Tops Q3 EPS by 2c; updates guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $102.92 --0%
Revenue Growth %: +5.5%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
CAN, UNFI, SUNB, More
Revenue Growth %: +5.5%
Financial Fact:
Operating income: 24.79M
Today's EPS Names:
CAN, UNFI, SUNB, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $1.19, $0.02 better than the analyst estimate of $1.17. Revenue for the quarter came in at $349 million versus the consensus estimate of $352.98 million.
GUIDANCE:
Haemonetics sees FY2025 EPS of $4.50-$4.70, versus the consensus of $4.59.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Double Downgrades Gulfport Energy (GPOR) to Underweight
- TD Cowen Reiterates Hold Rating on Leidos Holdings (LDOS)
- V.F. Corp. (VFC) September 15, February 11 and March 14 puts active
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
